Suven Pharmaceuticals Limited

NSE
SUVENPHAR
Stock
Yield per half year: -13.26%
Dividend yield: 0%
Sector: Healthcare

Share chart Suven Pharmaceuticals Limited

en.porti.ru1400.001400.001200.001200.001000.001000.00800.00800.00600.00600.00400.00400.00Feb '24Feb '24Mar '24Mar '24Apr '24Apr '24May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25
Download SVG
Download PNG
Download CSV

About Suven Pharmaceuticals Limited

Suven Pharmaceuticals Limited работает как биофармацевтическая компания в Индии, США, Европе и за рубежом. Она разрабатывает, производит и продает новые промежуточные химические соединения, активные фармацевтические ингредиенты, специальные химикаты и лекарственные препараты в рамках контрактных исследований и производственных услуг для фармацевтических, биотехнологических и химических компаний. Компания была зарегистрирована в 2018 году, ее штаб-квартира находится в Хайдарабаде, Индия.

more details
Suven Pharmaceuticals Limited является дочерней компанией Jasti Property and Equity Holdings Private Limited.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Main settings

ISIN INE03QK01018
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.921
Дивиденд ао 2
Сайт link
Цена ао 1092.1
Change price per day: 0% (1092.1)
Change price per week: +3.47% (1055.5)
Change price per month: -4.47% (1143.2)
Change price per 3 month: -9.66% (1208.9)
Change price per half year: -13.26% (1259.05)
Change price per year: +72.09% (634.6)
Change price per 3 year: +118.44% (499.95)
Change price per 5 year: +654.47% (144.75)
Change price per year to date: -2.2% (1116.65)
All parameters

Grade

Underestimation
Title Value Grade
P/S 15.74 1
P/BV 8.07 1
P/E 55.11 2
EV/EBITDA 35.42 2
Total: 3.5
Efficiency
Title Value Grade
ROA, % 14.23 4
ROE, % 15.86 5
Total: 5.67
Dividends
Title Value Grade
Div yield, % 0 0
DSI 0.75 7.5
Total: 3.26
Debt
Title Value Grade
Debt/EBITDA 0.139 10
Total: 10
Growth impulse
Title Value Grade
Yield Revenue, % 30.29 5
Yield Ebitda, % 5.82 1
Yield EPS, % -5.25 0
Total: 1.2
More

Similar companies

P/E & P/BVEV/Ebitda & Debt/Ebitda


Company management

Head Job title Payment Year of birth
Mr. Vaidheesh Annaswamy Executive Chairman N/A
Mr. Himanshu Agarwal Chief Financial Officer N/A 1970 (55 years)
Dr. Sudhir Kumar Singh Ph.D. Chief Executive Officer 1965 (60 years)
Ms. Cyndrella Carvalho Head of Investor Relations
Mr. Kundan Kumar Jha Company Secretary & Compliance Officer
Mr. Gaurav Narain Bahadur Chief Human Resources Officer 1970 (55 years)
Dr. Vetukuri Venkata Naga Kali Vara Prasada Raju MD & Director
Mr. Subba Raju Komaravolu Chief Strategy Officer
Mr. Brian Shaughnessy Chief Commercial Officer
Mr. Sunder Venkatraman Vice President of Corporate Affairs

About company

Address: India, Hyderabad, Galaxy Towers - Open in google maps, Open in yandex maps
Website: https://suvenpharm.com